Filter posts

American Invents Act Strategies Highlighted at the IPCC Conference

By David Saravitz, Alston + Bird Day 2 of the 2012 BIO Intellectual Property Counsels’ Committee …

BioManufacturers Increasing Budgets for New Technologies

By Eric Langer, Managing Partner, BioPlan Associates, Inc. Two-thirds Spending more for Improved Productivity Almost …

Biotech Patent Case Law Updates at the IPCC

By John W. Cox, Counsel at Alston+Bird LLP The Spring 2012 BIO Intellectual Property Counsels’ Committee …

The Life Sciences Foundation – Telling the Story of Biotechnology

By the Life Sciences Foundation “If a man were permitted to make all the ballads, …

Fox Trial Finder and You: Use It to Recruit for Your Trials or to Get Involved Yourself!

From The Michael J. Fox Foundation for Parkinson’s Research The Michael J. Fox Foundation has launched …

From Despair to Hope, a New World of Treatments

By David Welch, President and Senior Producer, M2 MultiMedia Communications Tonight, Wednesday March 28 at 9:00 …

Mayo v. Prometheus: BIO Statement on Supreme Court Decision

By Hans Sauer, Deputy General Counsel for Intellectual Property, Biotechnology Industry Organization We are surprised and …

Sen. Bob Menendez & William Waddill on the Therapeutic Discovery Project

Senator Bob Menendez (D-NJ), at the March 6th Senate Banking, Housing and Urban Affairs hearing, …

What Parallel Review Means for Manufacturers

By Stephen Rothenberg, J.D. and Matt Levy, J.D., Numerof & Associates, Inc. (NAI) Currently, the …

Patents for Humanity

By David Kappos, Director of the United States Patent and Trademark Office (USPTO) Originally Published on …